Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03952299 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oxybutynin for Post-surgical Bladder Pain and Urgency

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2025 to Dec 31, 2026v17
  2. 5 versions Re-verified since Sep 29, 2021, no change to tracked fieldsv12-v16
  3. Start date: Aug 1, 2021 to Sep 1, 2021v11
  4. Start date: Jun 1, 2021 to Aug 1, 2021v10
  5. Start date: Feb 1, 2021 to Jun 1, 2021v9
Show 7 earlier versionsHide 7 earlier versions
  1. Start date: Oct 1, 2020 to Feb 1, 2021v8
  2. Start date: Jul 1, 2020 to Oct 1, 2020v7
  3. Start date: May 1, 2020 to Jul 1, 2020v6
  4. Start date: Dec 1, 2019 to May 1, 2020v5
  5. Start date: Sep 2019 to Dec 1, 2019v4
  6. Start date: May 2019 to Sep 2019v3
  7. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.
Trial Details
NCT Number NCT03952299
Lead Sponsor University of California, Davis
Conditions
(from sponsor)		 Overactive Bladder Syndrome, Neuropathic Bladder
Related terms Urinary Bladder, Neurogenic
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov